Macrophage-mediated cardiac fibrosis

Circulation Research

Volumn 95, Issue 6, 2004, Pages 552-553

  Schulze, P Christian ^a   Lee, Richard T ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Partners Research Facility   (United States)

Author keywords

Fibrosis; Macrophage; Regeneration

Indexed keywords

ALDOSTERONE ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MATRIX METALLOPROTEINASE INHIBITOR; UROKINASE;

EDITORIAL; GENE OVEREXPRESSION; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART RUPTURE; HUMAN; HYPERTENSION; MACROPHAGE ACTIVATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REENTRY ARRHYTHMIA; REGENERATION; TISSUE INJURY; WOUND HEALING;

ANIMALS; EXTRACELLULAR MATRIX; FIBROSIS; HEART; HUMANS; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MYOCARDIAL INFARCTION; MYOCARDIUM; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRESSURE; REGENERATION; URINARY PLASMINOGEN ACTIVATOR; WOUND HEALING; ZEBRAFISH;

EID: 4644291112     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000143420.87587.9e     Document Type: Editorial

References (11)

1. Weber KT. Fibrosis in hypertensive heart disease: focus on cardiac fibroblasts. J Hypertension. 2004;22:47-50.
2. Fraccarollo D, Galuppo P, Hildemann S, Christ M, Ertl G, Bauersachs J. Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction. J Am Coll Cardiol. 2003; 42:1666-1673.
3. Hayashi M, Tsutamoto T, Wada A, Tsutsui T, Ishii C, Ohno K, Fujii M, Taniguchi A, Hamatani T, Nozato Y, Kataoka K, Morigami N, Ohnishi M, Kinoshita M, Horie M. Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction. Circulation. 2003;107:2559-2565.
4. Yarbrough WM, Mukherjee R, Escobar GP, Mingoia JT, Sample JA, Hendrick JW, Dowdy KB, McLean JE, Lowry AS, O'Neill TP, Spinale FG. Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling. Circulation. 2003;108: 1753-1759.
5. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE, Schoen FJ, Kelly RA, Werb Z, Libby P, Lee RT. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest. 2000;106:55-62.
6. Lindsey ML, Yoshioka J, MacGillivray C, Muangman S, Gannon J, Verghese A, Aikawa M, Libby P, Krane SM, Lee RT. Effect of a cleavage-resistant collagen mutation on left ventricular remodeling. Circ Res. 2003;93:238-245.
7. Poss KD, Wilson LG, Keating MT. Heart regeneration in zebrafish. Science. 2002;298:2188-2190.
8. Grose R, Martin P. Parallels between wound repair and morphogenesis in the embryo. Semin Cell Dev Biol. 1999;10:395-404.
9. Hopkinson-Woolley J, Hughes D, Gordon S, Martin P. Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse. J Cell Sci. 1994;107:1159-1167.
10. Moriwaki H, Stempien-Otero A, Kremen M, Cozen AE, Dichek DA. Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice. Circ Res. 2004;95:637-644.
11. Cozen AE, Moriwaki H, Kremen M, DeYoung MB, Dichek HL, Slezicki KI, Young SG, Veniant M, Dichek DA. Macrophage-targeted overexpression of urokinase causes accelerated atherosclerosis, coronary artery occlusions, and premature death. Circulation. 2004;109:2129-2135.